Literature DB >> 16836595

Cognitive training in Alzheimer's disease: a meta-analysis of the literature.

D I Sitzer1, E W Twamley, D V Jeste.   

Abstract

OBJECTIVE: To systematically review the literature and summarize the effect of cognitive training (CT) for Alzheimer's disease (AD) patients on multiple functional domains.
METHOD: Effect sizes (Cohen's d) were calculated for 17 controlled studies identified through a comprehensive literature review.
RESULTS: An overall effect size of 0.47 was observed for all CT strategies across all measured outcomes. Mean effect sizes were higher for restorative (0.54) than for compensatory (0.36) strategies. Domain-specific effect sizes ranged from 2.16 (verbal and visual learning) to -0.38 (visuospatial functioning). Data are also presented on the relative impact of restorative and compensatory strategies for each domain of functioning.
CONCLUSION: CT evidenced promise in the treatment of AD, with primarily medium effect sizes for learning, memory, executive functioning, activities of daily living, general cognitive problems, depression, and self-rated general functioning. Restorative strategies demonstrated the greatest overall effect on functioning. Several limitations of the published literature are discussed.

Entities:  

Mesh:

Year:  2006        PMID: 16836595     DOI: 10.1111/j.1600-0447.2006.00789.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  87 in total

1.  Targeting memory improvement in assisted living: a pilot study.

Authors:  Kristine N Williams
Journal:  Rehabil Nurs       Date:  2011 Nov-Dec       Impact factor: 1.625

Review 2.  Cognitive and memory training in adults at risk of dementia: a systematic review.

Authors:  Nicola J Gates; Perminder S Sachdev; Maria A Fiatarone Singh; Michael Valenzuela
Journal:  BMC Geriatr       Date:  2011-09-25       Impact factor: 3.921

3.  [Aspects of the report of the IQWiG (Institute for Quality and Cost Effectiveness in Public Health) " Cholinesterase inhibitors in Alzheimer's dementia"].

Authors:  Manfred Gogol; Dieter Lüttje; Hansjörg Werner
Journal:  Z Gerontol Geriatr       Date:  2007-06       Impact factor: 1.281

4.  Repetitive transcranial magnetic stimulation (rTMS) combined with cognitive training is a safe and effective modality for the treatment of Alzheimer's disease: clinical experience.

Authors:  Jose Martin Rabey; Evgenia Dobronevsky
Journal:  J Neural Transm (Vienna)       Date:  2016-09-08       Impact factor: 3.575

5.  Brief report: is cognitive rehabilitation needed in verbal adults with autism? Insights from initial enrollment in a trial of cognitive enhancement therapy.

Authors:  Shaun M Eack; Amber L Bahorik; Susan S Hogarty; Deborah P Greenwald; Maralee Y Litschge; Carla A Mazefsky; Nancy J Minshew
Journal:  J Autism Dev Disord       Date:  2013-09

6.  Enhanced cognitive activity--over and above social or physical activity--is required to protect Alzheimer's mice against cognitive impairment, reduce Abeta deposition, and increase synaptic immunoreactivity.

Authors:  Jennifer R Cracchiolo; Takashi Mori; Stanley J Nazian; Jun Tan; Huntington Potter; Gary W Arendash
Journal:  Neurobiol Learn Mem       Date:  2007-08-21       Impact factor: 2.877

7.  Cognitive interventions for older adults: does approach matter?

Authors:  Kristine Williams; Ruth Herman; Erin Kate Smith
Journal:  Geriatr Nurs       Date:  2014-02-20       Impact factor: 2.361

8.  Latest Advances on Interventions that May Prevent, Delay or Ameliorate Dementia.

Authors:  Danielle Wilson; Ruth Peters; Karen Ritchie; Craig W Ritchie
Journal:  Ther Adv Chronic Dis       Date:  2011-05       Impact factor: 5.091

9.  Detection of visuoperceptual deficits in preclinical and mild Alzheimer's disease.

Authors:  Montse Alegret; Mercè Boada-Rovira; Georgina Vinyes-Junqué; Sergi Valero; Ana Espinosa; Isabel Hernández; Gemma Modinos; Maitee Rosende-Roca; Ana Mauleón; James T Becker; Lluís Tárraga
Journal:  J Clin Exp Neuropsychol       Date:  2009-01-14       Impact factor: 2.475

Review 10.  Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia.

Authors:  David B Hogan; Peter Bailey; Sandra Black; Anne Carswell; Howard Chertkow; Barry Clarke; Carole Cohen; John D Fisk; Dorothy Forbes; Malcolm Man-Son-Hing; Krista Lanctôt; Debra Morgan; Lilian Thorpe
Journal:  CMAJ       Date:  2008-11-04       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.